ABSTRACT
We report a case of neonatal subdural empyema caused by Mycoplasma hominis. The infant sustained severe birth-related eye injury and subsequently developed multiple subdural empyemata. This report illustrates the clinical presentation of this unusual infection and the crucial role of neurosurgical intervention and specific antimicrobial therapy for its successful management.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Empyema, Subdural/drug therapy , Minocycline/therapeutic use , Mycoplasma Infections/drug therapy , Mycoplasma hominis/isolation & purification , Birth Injuries/etiology , Birth Injuries/microbiology , Birth Injuries/pathology , Empyema, Subdural/microbiology , Empyema, Subdural/pathology , Eye Injuries/etiology , Eye Injuries/microbiology , Eye Injuries/pathology , Female , Humans , Infant, Newborn , Injections, Intravenous , Microbial Sensitivity Tests , Mycoplasma Infections/complications , Mycoplasma Infections/pathology , Mycoplasma hominis/physiology , Obstetrical Forceps/adverse effects , Treatment OutcomeABSTRACT
Neonatal Escherichia coli meningitis is a serious disease with high mortality and poor outcome. Ventriculitis, brain abscess and subdural empyema are frequent, with no homogeneous recommendations available for these complications. The case of a newborn infant who developed sepsis and meningitis caused by E. coli is presented. During intravenous treatment with ampicillin, cefotaxime and gentamycin in recommended doses, the patient developed severe subdural abscesses detected on MRI. After consequent antibiotic therapy over 2 months with fosfomycin, amikacin and meropenem the patient improved clinically and the abscesses regressed and disappeared without neurosurgical intervention. At the age of 6.5 months the infant is healthy and well developed. The conservative treatment of subdural abscesses complicating neonatal Escherichia coli meningitis without neurosurgical intervention is possible. The treatment of the individual case should be discussed between pediatrician and neurosurgeon.
Subject(s)
Drug Therapy, Combination/therapeutic use , Empyema, Subdural/drug therapy , Escherichia coli Infections/drug therapy , Meningitis, Escherichia coli/drug therapy , Amikacin/administration & dosage , Brain/pathology , Echoencephalography , Empyema, Subdural/diagnosis , Escherichia coli Infections/diagnosis , Female , Fosfomycin/administration & dosage , Humans , Infant, Newborn , Intensive Care, Neonatal , Magnetic Resonance Imaging , Meningitis, Escherichia coli/diagnosis , Meropenem , Microbial Sensitivity Tests , Patient Care Team , Thienamycins/administration & dosage , Treatment OutcomeABSTRACT
Cases of intracranial sepsis of otorhinogenic origin presenting to a regional neurosurgical centre from 1984 to 1992 were examined with regard to their microbiology and antibiotic sensitivities. The results lead us to believe that cefotaxime may have a role in the initial ENT management of the potentially complicated case of ear or sinus sepsis.
Subject(s)
Brain Abscess/drug therapy , Cefotaxime/therapeutic use , Empyema, Subdural/drug therapy , Otitis Media/complications , Sinusitis/complications , Bacteria/drug effects , Brain Abscess/microbiology , Brain Abscess/surgery , Chloramphenicol/therapeutic use , Empyema, Subdural/microbiology , Empyema, Subdural/surgery , Humans , Metronidazole/therapeutic use , Microbial Sensitivity Tests , Penicillins/therapeutic useABSTRACT
Treatment of infections after neurosurgical operations at the head and vertebral column is lengthy and stressful for the patient. Hence, we implanted--as has been routine in septic bone surgery for a long time--carriers of antibiotics for local antibiotic therapy in the form of Septopal chains. The course of treatment and the results obtained in 16 patients are presented. In all patients the wound cavities were filled with Septopal chains after débridement. In the course of 6-12 days the chains projecting from the skin by a stab incision were extracted sphere by sphere. The treated wound healed immediately in 14 patients; healing was delayed in 2 patients, but there were no complications. Since the use of Septopal chains results in local gentamicin levels which are so high that the conventional classification of germs into gentamicin-sensitive/gentamicin-resistant is of minor importance, the wounds healed without complications even in those patients where the germs had been classified as "resistant" in the routine antibiogram. Thus, Septopal offers the advantage of primary wound closure without secondary contamination or scatter into the environment (intensive-care ward!), shorter treatment time, reduced stress for the patient and more rapid mobilisation.